NASHVILLE, Tennessee, Aug. 11 -- Vanderbilt University Medical Center posted the following news release:

* * *

Vanderbilt Health evaluating vaccine for C. difficile for people 65 and older

*

Investigators at Vanderbilt Health are enrolling participants in a Phase 3 clinical trial testing an investigational vaccine against Clostridioides difficile, or C. diff, a contagious bacterial infection of the colon.

C. diff is a leading caus . . .

Click here for more information about our products